Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.

Dostálová I, Kaválková P, Haluzíková D, Lacinová Z, Mráz M, Papezová H, Haluzík M.

J Clin Endocrinol Metab. 2008 Sep;93(9):3627-32. doi: 10.1210/jc.2008-0746. Epub 2008 Jun 17.

PMID:
18559909
2.
3.

Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines.

Dostálová I, Smitka K, Papezová H, Kvasnicková H, Nedvídková J.

Physiol Res. 2007;56(5):587-94. Epub 2006 Dec 19.

4.

Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.

Tan BK, Hallschmid M, Adya R, Kern W, Lehnert H, Randeva HS.

Diabetes. 2011 Nov;60(11):2758-62. doi: 10.2337/db11-0672. Epub 2011 Sep 16.

5.

Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents.

Mikolajczak A, Oswiecimska JM, Swietochowska E, Roczniak W, Ziora KT.

Neuro Endocrinol Lett. 2017 Jul;38(3):173-181.

PMID:
28759185
6.

Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.

Gallego-Escuredo JM, Domingo P, Gutiérrez Mdel M, Mateo MG, Cabeza MC, Fontanet A, Vidal F, Domingo JC, Giralt M, Villarroya F.

J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):527-34. doi: 10.1097/QAI.0b013e318271c2c7.

PMID:
23187887
7.

Hyperadiponectinaemia in anorexia nervosa.

Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M.

Clin Endocrinol (Oxf). 2003 Jan;58(1):22-9.

PMID:
12519408
8.

Preadipocyte factor-1 concentrations in patients with anorexia nervosa: the influence of partial realimentation.

Kaválková P, Dostálová I, Haluzíková D, Trachta P, Hanušová V, Lacinová Z, Papežová H, Domluvilová D, Zikán V, Haluzík M.

Physiol Res. 2012;61(2):153-9. Epub 2012 Jan 31.

9.

Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression.

Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M.

Clin Endocrinol (Oxf). 2007 Nov;67(5):674-8.

PMID:
17953628
10.

Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa.

Housova J, Anderlova K, Krizová J, Haluzikova D, Kremen J, Kumstyrová T, Papezová H, Haluzik M.

J Clin Endocrinol Metab. 2005 Mar;90(3):1366-70. Epub 2004 Dec 14.

PMID:
15598689
11.

Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients.

Modan-Moses D, Stein D, Pariente C, Yaroslavsky A, Ram A, Faigin M, Loewenthal R, Yissachar E, Hemi R, Kanety H.

J Clin Endocrinol Metab. 2007 May;92(5):1843-7. Epub 2007 Feb 27.

PMID:
17327386
12.

[Determination of insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbid obesity and anorexia nervosa after therapeutic intervention].

Escobar L, Freire JM, Espinosa R, Pajares M, Girón JA, Vázquez JM, Chover A, Carrasco M, Ortero J, Gavilán I, Segura E, Aguilar M.

Rev Esp Med Nucl. 2002 Feb;21(1):3-11. Spanish.

13.

[Serum leptin levels and soluble leptin receptors in female patients with anorexia nervosa].

Jiskra J, Haluzík M, Svobodová J, Haluzíková D, Nedvídková J, Parízková J, Kotrlíková E.

Cas Lek Cesk. 2000 Oct 25;139(21):660-3. Czech.

PMID:
11192764
14.

Adipose tissue resistin levels in patients with anorexia nervosa.

Dostalova I, Kunesova M, Duskova J, Papezova H, Nedvidkova J.

Nutrition. 2006 Oct;22(10):977-83. Epub 2006 Aug 2.

PMID:
16889937
15.

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Matoulek M, Dostalova I, Humenanska V, Haluzik M.

Clin Endocrinol (Oxf). 2009 Sep;71(3):369-75. doi: 10.1111/j.1365-2265.2008.03502.x. Epub 2008 Dec 11.

PMID:
19702724
16.

FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.

Gómez-Ambrosi J, Gallego-Escuredo JM, Catalán V, Rodríguez A, Domingo P, Moncada R, Valentí V, Salvador J, Giralt M, Villarroya F, Frühbeck G.

Clin Nutr. 2017 Jun;36(3):861-868. doi: 10.1016/j.clnu.2016.04.027. Epub 2016 May 4.

PMID:
27188262
17.

Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.

Durovcová V, Marek J, Hána V, Matoulek M, Zikán V, Haluzíková D, Kaválková P, Lacinová Z, Krsek M, Haluzík M.

Physiol Res. 2010;59(3):415-22. Epub 2009 Aug 12.

18.

Serum leptin levels in women with anorexia nervosa.

Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A.

J Clin Endocrinol Metab. 1996 Nov;81(11):3861-3.

PMID:
8923829
19.

Determinants of plasma adiponectin levels in patients with anorexia nervosa examined before and after weight gain.

Bosy-Westphal A, Brabant G, Haas V, Onur S, Paul T, Nutzinger D, Klein H, Hauer M, Müller MJ.

Eur J Nutr. 2005 Sep;44(6):355-9. Epub 2005 Apr 4.

PMID:
15793670
20.

[Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively].

Escobar L, Freire JM, Girón JA, Vázquez JM, Pajares M, Ortego J, Gavilán I, Chover AJ, Carrasco M, Epinosa R, Marín F, Aguilar M.

Rev Esp Med Nucl. 2000 Jun;19(3):199-206. Spanish.

Supplemental Content

Support Center